native IGF-1 Short half-life (~2030 minutes) highly suited for site-specific injection and local tissue effects Why Was IGF-1 DES Developed
These pathways not only preserve proteome integrity but also offer powerful therapeutic opportunities, as demonstrated by the emergence of proteasome inhibitors, autophagy modulators, and molecular chaperone-targeting agents in clinical medicine (Tables 1 and 2)
Although direct neo-N-terminal fragments of caspase-1 were not enriched in the TMT-TAILS dataset, potentially due to labeling inefficiencies, we observed significant depletion of peptides spanning the X(PC) cleavage site in the active protease-treated samples, providing strong evidence of on-target cleavage (Extended Data Fig
When glutathione levels decrease, for example, due to stress or nutritional deficiencies, the risk of catching a cold, getting infections, feeling constantly fatigued, or experiencing sleep disturbances significantly increases